NSW Health logs 1,180 emergency visits tied to unapproved peptides
Monthly presentations rose from five in July 2025 to more than 217 in September 2026, with clinicians reporting kidney and liver injury.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 19 20:22 ETSource: Pharmacy Daily
The wire
- 01Surveillance data cover 1 July 2025 to 30 September 2026 and involve products claiming to contain BPC-157, GHK-Cu, TB-500, retatrutide and CJC-1295.
- 02Health Minister Ryan Park warned that professional packaging is no guarantee of safety, and urged people to avoid products sold via social media, online retailers and informal sellers.
- 03NSW Health says products may be mislabelled or contain different strengths or substances; the data are presentation counts, not confirmed causation or product testing.
From the source
Read at pharmacydaily.com.auSurge in peptide hospital visits
NSW Health yesterday released new data showing a sharp increase in emergency department presentations associated with the use of unapproved peptides. Surveillance data revealed 1,180 presentations to NSW emergency departments associated with peptide use between 01 Jul 2025 and 30 Sep 2026. Monthly presentations increased from just five in Jul...
